Peripheral Vascular Devices Market worth $13.4 billion by 2026...

Peripheral Vascular Devices Market worth $13.4 billion by 2026 Global Market Trends in healthcare industry

Posted 2023-02-27 06:30:53

171

The global peripheral vascular devices market is expected to experience a significant growth in the coming years. This is driven by the increasing prevalence of peripheral vascular diseases (PVDs), technological advancements in the field, and increasing number of clinical trials. Furthermore, the rising geriatric population and increasing awareness about the treatment options are also expected to propel the growth of the market.

Peripheral vascular devices are medical devices used in the diagnosis and treatment of PVDs. These devices include stents, angioplasty balloons, catheters, and guidewires. Stents are used to treat blockages or narrowing of blood vessels, while angioplasty balloons are used to open up a blocked artery. Catheters are used to measure blood pressure, while guidewires are used to guide the catheters.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790

The global peripheral vascular devices market is segmented based on product type, end-user, and geography. On the basis of product type, the market is segmented into stents, angioplasty balloons, catheters, and guidewires. On the basis of end-user, the market is segmented into hospitals, clinics, and ambulatory care centers. Geographically, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

North America is expected to dominate the global peripheral vascular devices market due to the presence of a large number of PVD patients and rising demand for advanced treatments. Europe is expected to be the second largest market due to the increasing prevalence of PVDs and the presence of a large number of healthcare facilities. Asia-Pacific is expected to witness the highest growth due to the increasing awareness about the treatment options, rising geriatric population, and increasing government support.

Key Market Players

The major players in the peripheral vascular devices market Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Cardinal Health (US), B. Braun Melsungen AG (US), Merit Medical Systems (US), Penumbra, Inc.(US), Koninklijke Philips N.V.( Netherlands), iVascular S.L.U (Spain), Biosensors International Group Ltd. (Singapore), BIOTRONIK (Germany), AMG International GmbH (US), ENDOCOR GmbH (Germany).

Medtronic (Ireland) held the leading position in the peripheral vascular devices market. The company offers an exhaustive product portfolio consisting of various peripheral vascular devices. The company’s strong heritage of technology, leadership, and innovation has provided a solid foundation for the continued development of safe and cost-effective products.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=790

This research report categorizes the peripheral vascular devices market into the following segments and sub-segments:

By Product

Angioplasty Balloons
Angioplasty Stents
Catheters
Endovascular Aneurysm Repair Stent Grafts
Inferior Vena Cava Filters
Plaque Modification Devices
Hemodynamic Flow Alteration Device Market
Other Peripheral Vascular Devices

By Region

North America
Europe
Asia Pacific
Rest of the World

Recent Developments:

Medtronic received the US FDA approval for its IN. PACT AV drug-coated balloon (DCB) to treat arteriovenous fistula lesions
Boston Scientific Corporation received the FDA Approval for its VICI VENOUS STENT System for treating patients with deep venous blockages.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=790

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/interventional-cardiology-peripheral-vascular-devices-market.asp

Visit Our Web Site: https://www.marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/peripheral-vascular-devices.asp